Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

NCT00052403 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was not successful at recruiting particpants

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: monoclonal antibody anti-anb3 integrin
PROCEDURE: anti-cytokine therapy
PROCEDURE: antiangiogenesis therapy
PROCEDURE: antibody therapy
PROCEDURE: biological response modifier therapy
PROCEDURE: growth factor antagonist therapy
PROCEDURE: monoclonal antibody therapy

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]